Report Description:

Global Data’s Medical Devices sector report, Insulin Delivery – Pipeline Review, 2015″ provides an overview of Insulin Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Delivery pipeline products.

Browse Full Report with Toc Visit: http://www.acutemarketreports.com/report/insulin-delivery-pipeline-review-2015

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope:

Extensive coverage of the Insulin Delivery products under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Insulin Delivery and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Browse All Reports Of This Category: http://www.acutemarketreports.com/category/medical-equipments-market

Reasons to buy:

The report enables you to –

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Insulin Delivery under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the products current stage of development, territory and estimated launch date

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 Introduction 7

2.1 Insulin Delivery Overview 7

Download Free Request Sample: http://www.acutemarketreports.com/checkout/48492

3 Products under Development 8

3.1 Insulin Delivery – Pipeline Products by Stage of Development 8

3.2 Insulin Delivery – Pipeline Products by Segment 9

3.3 Insulin Delivery – Pipeline Products by Territory 10

3.4 Insulin Delivery – Pipeline Products by Regulatory Path 11

3.5 Insulin Delivery – Pipeline Products by Estimated Approval Date 12

3.6 Insulin Delivery – Ongoing Clinical Trials 13

4 Insulin Delivery – Pipeline Products under Development by Companies 14

4.1 Insulin Delivery Companies – Pipeline Products by Stage of Development 14

4.2 Insulin Delivery – Pipeline Products by Stage of Development 16

5 Insulin Delivery Companies and Product Overview 17

5.1 Amrita Vishwa Vidyapeetham Company Overview 17

5.1.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17

5.2 Andain, Inc Company Overview 18

5.2.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.3 AstraZeneca PLC Company Overview 20

5.3.1 AstraZeneca PLC Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 Becton, Dickinson and Company Company Overview 22

5.4.1 Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 22

5.5 Cellnovo Ltd. Company Overview 24

5.5.1 Cellnovo Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24

5.6 CeQur SA Company Overview 26

5.6.1 CeQur SA Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 Companion Medical Company Overview 29

5.7.1 Companion Medical Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 ConvaTec Healthcare B S.a.r.l. Company Overview 30

5.8.1 ConvaTec Healthcare B S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 Dance Biopharm Inc. Company Overview 31

5.9.1 Dance Biopharm Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 Debiotech S.A. Company Overview 32

5.10.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 InsuLenz Company Overview 37

5.11.1 InsuLenz Pipeline Products & Ongoing Clinical Trials Overview 37

5.12 Insulet Corporation Company Overview 38

5.12.1 Insulet Corporation Pipeline Products & Ongoing Clinical Trials Overview 38

5.13 InsuLine Medical Ltd. Company Overview 40

5.13.1 InsuLine Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40

5.14 LifeScan, Inc. Company Overview 45

5.14.1 LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45

5.15 Medical International Technologies (Mit Canada) Inc. Company Overview 47

5.15.1 Medical International Technologies (Mit Canada) Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

5.16 MedSolve Technologies, Inc. Company Overview 49

5.16.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

5.17 MicroPort Scientific Corporation Company Overview 50

5.17.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 50

5.18 North Carolina State University Company Overview 52

5.18.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 52

5.19 Sanofi Company Overview 54

5.19.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview 54

5.20 SFC Fluidics LLC Company Overview 56

5.20.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 56

5.21 Spring Health Solutions Ltd. Company Overview 57

5.21.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 57

5.22 Transdermal Specialties, Inc. Company Overview 59

5.22.1 Transdermal Specialties, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59

5.23 University of KwaZulu-Natal Company Overview 60

5.23.1 University of KwaZulu-Natal Pipeline Products & Ongoing Clinical Trials Overview 60

5.24 University of Toronto Company Overview 61

5.24.1 University of Toronto Pipeline Products & Ongoing Clinical Trials Overview 61

5.25 Ypsomed Holding AG Company Overview 62

5.25.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 62

Browse All Reports Of This Publisher: http://www.acutemarketreports.com/publisher/globaldata

Acute Market Reports:

About Us:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.  We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Contact Us:
Chris Paul
Sales Manager
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email: sales@acutemarketreports.com
Web: AcuteMarketReports